|
|
|
|
|
Detail |
| hsa-miR-196a |
|
Unspecified |
MicroRNA gene expression deregulation in human breast cancer. |
2005 |
|
|
|
|
|
|
| hsa-miR-196a |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-196a |
|
Unspecified |
MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease |
2009 |
|
|
|
|
|
|
| hsa-miR-196a |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
| hsa-miR-196a |
|
Causal |
MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. |
2008 |
|
|
|
|
|
|
| hsa-miR-196a |
|
Unspecified |
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. |
2008 |
|
|
|
|
|
|
| hsa-miR-196a |
|
Causal |
MicroRNA-196a is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus. |
2009 |
|
|
|
|
|
|
| hsa-miR-196a |
|
Causal |
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. |
2009 |
|
|
|
|
|
|